The ideal inhaler for asthma therapy.
Innovations in multidose nebulisers and dry-powder inhalation devices have been stimulated by the development of new chemical entities and the availability of generic drugs. In addition, conventional pressurised inhalers are being replaced because of the phasing-out of chlorofluorocarbon gases. This article highlights the key features that constitute the ideal inhaler.
Buck
H
H
Innovata Biomed Ltd, St Albans, UK. hbuck@innovatabiomed.com
D000280:Administration, Inhalation; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy* / Q000191:economics; D016503:Drug Delivery Systems / Q000295:instrumentation* / Q000379:methods; D004867:Equipment Design; D006801:Humans; D009330:Nebulizers and Vaporizers; D010342:Patient Acceptance of Health Care; D013673:Technology Assessment, Biomedical / Q000379:methods*
D018927:Anti-Asthmatic Agents